Abstract
The difficulty to understand, diagnose, and treat neurological disorders stems from the great complexity of the central nervous system on different levels of physiological granularity. The individual components, their interactions, and dynamics involved in brain development and function can be represented as molecular, cellular, or functional networks, where diseases are perturbations of networks. These networks can become a useful research tool in investigating neurological disorders if they are properly tailored to reflect corresponding mechanisms. Here, we review approaches to construct networks specific for neurological disorders describing disease-related pathology on different scales: the molecular, cellular, and brain level. We also briefly discuss cross-scale network analysis as a necessary integrator of these scales.
If you look at the anatomy, the structure, the function, there's nothing in the universe that’s more beautiful, that’s more complex, than the human brain. Keith Black
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Parker MH, Seale P, Rudnicki MA (2003) Looking back to the embryo: defining transcriptional networks in adult myogenesis. Nat Rev Genet 4:497–507. doi:10.1038/nrg1109
Drake CJ (2003) Embryonic and adult vasculogenesis. Birth Defects Res C Embryo Today 69:73–82. doi:10.1002/bdrc.10003
Urbán N, Guillemot F (2014) Neurogenesis in the embryonic and adult brain: same regulators, different roles. Front Cell Neurosci. doi:10.3389/fncel.2014.00396
Sharan R, Ideker T (2006) Modeling cellular machinery through biological network comparison. Nat Biotechnol 24:427–433. doi:10.1038/nbt1196
Edelman LB, Chandrasekaran S, Price ND (2010) Systems biology of embryogenesis. Reprod Fertil Dev 22:98–105. doi:10.1071/RD09215
Stiles J, Jernigan TL (2010) The basics of brain development. Neuropsychol Rev 20:327–348. doi:10.1007/s11065-010-9148-4
Kintner C (2002) Neurogenesis in embryos and in adult neural stem cells. J Neurosci 22:639–643
Gilbert SF (2000) Developmental biology, 6th edn. Sinauer Associates, Sunderland, MA
Sporns O, Tononi G, Kötter R (2005) The human connectome: a structural description of the human brain. PLoS Comput Biol 1:e42. doi:10.1371/journal.pcbi.0010042
Spitzer NC (2006) Electrical activity in early neuronal development. Nature 444:707–712. doi:10.1038/nature05300
Rhinn M, Brand M (2001) The midbrain--hindbrain boundary organizer. Curr Opin Neurobiol 11:34–42
Joyner AL (1996) Engrailed, Wnt and Pax genes regulate midbrain--hindbrain development. Trends Genet 12:15–20
Bozzi Y, Casarosa S, Caleo M (2012) Epilepsy as a neurodevelopmental disorder. Front Psychiatry 3:19. doi:10.3389/fpsyt.2012.00019
Nissim-Eliraz E, Zisman S, Schatz O, Ben-Arie N (2013) Nato3 integrates with the Shh-Foxa2 transcriptional network regulating the differentiation of midbrain dopaminergic neurons. J Mol Neurosci 51:13–27. doi:10.1007/s12031-012-9939-6
Rogers D, Schor NF (2010) The child is father to the man: developmental roles for proteins of importance for neurodegenerative disease. Ann Neurol 67:151–158. doi:10.1002/ana.21841
Kolodkin A, Simeonidis E, Balling R, Westerhoff HV (2012) Understanding complexity in neurodegenerative diseases: in silico reconstruction of emergence. Front Physiol 3:291. doi:10.3389/fphys.2012.00291
Thiele I, Palsson BØ (2010) A protocol for generating a high-quality genome-scale metabolic reconstruction. Nat Protoc 5:93–121
Head MW (2013) Human prion diseases: molecular, cellular and population biology. Neuropathology 33:221–236. doi:10.1111/neup.12016
Tycko R, Wickner RB (2013) Molecular structures of amyloid and prion fibrils: consensus versus controversy. Acc Chem Res 46:1487–1496. doi:10.1021/ar300282r
Ortega Z, Lucas JJ (2014) Ubiquitin-proteasome system involvement in Huntington’s disease. Front Mol Neurosci 7:77. doi:10.3389/fnmol.2014.00077
Nacmias B, Piaceri I, Bagnoli S et al (2014) Genetics of Alzheimer’s disease and frontotemporal dementia. Curr Mol Med 14:993–1000
Petrucci S, Consoli F, Valente EM (2014) Parkinson disease genetics: a “Continuum” from mendelian to multifactorial inheritance. Curr Mol Med 14:1079–1088
Lignani G, Raimondi A, Ferrea E et al (2013) Epileptogenic Q555X SYN1 mutant triggers imbalances in release dynamics and short-term plasticity. Hum Mol Genet 22:2186–2199. doi:10.1093/hmg/ddt071
Oliva M, Berkovic SF, Petrou S (2012) Sodium channels and the neurobiology of epilepsy. Epilepsia 53:1849–1859. doi:10.1111/j.1528-1167.2012.03631.x
Margineanu DG (2013) Systems biology, complexity, and the impact on antiepileptic drug discovery. Epilepsy Behav. doi:10.1016/j.yebeh.2013.08.029
Cui S, Sun H, Gu X et al (2014) Gene expression profiling analysis of locus coeruleus in idiopathic Parkinson’s disease by bioinformatics. Neurol Sci. doi:10.1007/s10072-014-1889-z
Winden KD, Karsten SL, Bragin A et al (2011) A systems level, functional genomics analysis of chronic epilepsy. PLoS One 6:e20763. doi:10.1371/journal.pone.0020763
Tauber E, Miller-Fleming L, Mason RP et al (2011) Functional gene expression profiling in yeast implicates translational dysfunction in mutant huntingtin toxicity. J Biol Chem 286:410–419. doi:10.1074/jbc.M110.101527
Hwang D, Lee IY, Yoo H et al (2009) A systems approach to prion disease. Mol Syst Biol 5:252. doi:10.1038/msb.2009.10
Marbiah MM, Harvey A, West BT et al (2014) Identification of a gene regulatory network associated with prion replication. EMBO J 33:1527–1547. doi:10.15252/embj.201387150
Manogaran AL, Hong JY, Hufana J et al (2011) Prion formation and polyglutamine aggregation are controlled by two classes of genes. PLoS Genet 7:e1001386. doi:10.1371/journal.pgen.1001386
Tourette C, Li B, Bell R et al (2014) A large scale Huntingtin protein interaction network implicates Rho GTPase signaling pathways in Huntington disease. J Biol Chem 289:6709–6726. doi:10.1074/jbc.M113.523696
Rakshit H, Rathi N, Roy D (2014) Construction and analysis of the protein-protein interaction networks based on gene expression profiles of Parkinson’s disease. PLoS One 9:e103047. doi:10.1371/journal.pone.0103047
Dusonchet J, Li H, Guillily M et al (2014) A Parkinson’s disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity. Hum Mol Genet 23:4887–4905. doi:10.1093/hmg/ddu202
Chandrasekaran S, Bonchev D (2013) A network view on Parkinson’s disease. Comput Struct Biotechnol J 7:e201304004. doi:10.5936/csbj.201304004
Armananzas R, Larranaga P, Bielza C (2012) Ensemble transcript interaction networks: a case study on Alzheimer’s disease. Comput Methods Programs Biomed 108:442–450. doi:10.1016/j.cmpb.2011.11.011
Liu Z-P, Wang Y, Zhang X-S et al (2011) Detecting and analyzing differentially activated pathways in brain regions of Alzheimer’s disease patients. Mol Biosyst 7:1441–1452. doi:10.1039/c0mb00325e
Bando SY, Alegro MC, Amaro EJ et al (2011) Hippocampal CA3 transcriptome signature correlates with initial precipitating injury in refractory mesial temporal lobe epilepsy. PLoS One 6:e26268. doi:10.1371/journal.pone.0026268
Kanehisa M, Limviphuvadh V, Tanabe M (2010) Chapter 9 knowledge-based analysis of protein interaction networks in neurodegenerative diseases. In: Alzate O (ed) Neuroproteomics. CRC Press, Boca Raton, pp 1–17
Sertbas M, Ulgen K, Cakir T (2014) Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network. FEBS Open Bio 4:542–553. doi:10.1016/j.fob.2014.05.006
Crespo I, Roomp K, Jurkowski W et al (2012) Gene regulatory network analysis supports inflammation as a key neurodegeneration process in prion disease. BMC Syst Biol 6:132. doi:10.1186/1752-0509-6-132
Mayburd A, Baranova A (2013) Knowledge-based compact disease models identify new molecular players contributing to early-stage Alzheimer’s disease. BMC Syst Biol 7:121. doi:10.1186/1752-0509-7-121
Lee SM, Chung M, Hwang KJ et al (2014) Biological network inferences for a protection mechanism against familial Creutzfeldt-Jakob disease with E200K pathogenic mutation. BMC Med Genomics 7:52. doi:10.1186/1755-8794-7-52
Bakir-Gungor B, Baykan B, Ugur Iseri S et al (2013) Identifying SNP targeted pathways in partial epilepsies with genome-wide association study data. Epilepsy Res 105:92–102. doi:10.1016/j.eplepsyres.2013.02.008
Edwards YJK, Beecham GW, Scott WK et al (2011) Identifying consensus disease pathways in Parkinson’s disease using an integrative systems biology approach. PLoS One 6:e16917. doi:10.1371/journal.pone.0016917
Ogishima S, Mizuno S, Kikuchi M et al (2013) A map of Alzheimer’s disease-signaling pathways: a hope for drug target discovery. Clin Pharmacol Ther 93:399–401. doi:10.1038/clpt.2013.37
Fujita KA, Ostaszewski M, Matsuoka Y et al (2014) Integrating pathways of Parkinson’s disease in a molecular interaction map. Mol Neurobiol 49:88–102. doi:10.1007/s12035-013-8489-4
Ouzounoglou E, Kalamatianos D, Emmanouilidou E et al (2014) In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis. BMC Syst Biol 8:54. doi:10.1186/1752-0509-8-54
Buchel F, Saliger S, Drager A et al (2013) Parkinson’s disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of alpha-synuclein. BMC Neurosci 14:136. doi:10.1186/1471-2202-14-136
Palomero-Gallagher N, Schleicher A, Bidmon H-J et al (2012) Multireceptor analysis in human neocortex reveals complex alterations of receptor ligand binding in focal epilepsies. Epilepsia 53:1987–1997. doi:10.1111/j.1528-1167.2012.03634.x
Mirza N, Vasieva O, Marson AG, Pirmohamed M (2011) Exploring the genomic basis of pharmacoresistance in epilepsy: an integrative analysis of large-scale gene expression profiling studies on brain tissue from epilepsy surgery. Hum Mol Genet 20:4381–4394. doi:10.1093/hmg/ddr365
Qi Z, Miller GW, Voit EO (2014) Rotenone and paraquat perturb dopamine metabolism: a computational analysis of pesticide toxicity. Toxicology 315:92–101. doi:10.1016/j.tox.2013.11.003
Rhodes SL, Buchanan DD, Ahmed I et al (2014) Pooled analysis of iron-related genes in Parkinson’s disease: association with transferrin. Neurobiol Dis 62:172–178. doi:10.1016/j.nbd.2013.09.019
Wexler EM, Rosen E, Lu D et al (2011) Genome-wide analysis of a Wnt1-regulated transcriptional network implicates neurodegenerative pathways. Sci Signal 4:ra65. doi:10.1126/scisignal.2002282
Chatterjee P, Bhattacharyya M, Bandyopadhyay S, Roy D (2014) Studying the system-level involvement of microRNAs in Parkinson’s disease. PLoS One 9:e93751. doi:10.1371/journal.pone.0093751
Satoh J (2012) Molecular network of microRNA targets in Alzheimer’s disease brains. Exp Neurol 235:436–446. doi:10.1016/j.expneurol.2011.09.003
Jimenez-Mateos EM, Henshall DC (2013) Epilepsy and microRNA. Neuroscience 238:218–229. doi:10.1016/j.neuroscience.2013.02.027
Stilling RM, Ronicke R, Benito E et al (2014) K-Lysine acetyltransferase 2a regulates a hippocampal gene expression network linked to memory formation. EMBO J 33:1912–1927. doi:10.15252/embj.201487870
Li Y, Chen JA, Sears RL et al (2014) An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy. PLoS Genet 10:e1004211. doi:10.1371/journal.pgen.1004211
Li G, Jiang H, Chang M et al (2011) HDAC6 alpha-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases. J Neurol Sci 304:1–8. doi:10.1016/j.jns.2011.02.017
Santiago JA, Potashkin JA (2014) System-based approaches to decode the molecular links in Parkinson’s disease and diabetes. Neurobiol Dis. doi:10.1016/j.nbd.2014.03.019
Menon R, Farina C (2011) Shared molecular and functional frameworks among five complex human disorders: a comparative study on interactomes linked to susceptibility genes. PLoS One 6:e18660. doi:10.1371/journal.pone.0018660
Tu Z, Keller MP, Zhang C et al (2012) Integrative analysis of a cross-loci regulation network identifies App as a gene regulating insulin secretion from pancreatic islets. PLoS Genet 8:e1003107. doi:10.1371/journal.pgen.1003107
Schluesener JK, Zhu X, Schluesener HJ et al (2014) Key network approach reveals new insight into Alzheimer’s disease. IET Syst Biol 8:169–175. doi:10.1049/iet-syb.2013.0047
Llorens F, Del Rio JA (2012) Unraveling the neuroprotective mechanisms of PrP (C) in excitotoxicity. Prion 6:245–251. doi:10.4161/pri.19639
Rial D, Pamplona FA, Moreira ELG et al (2014) Cellular prion protein is present in dopaminergic neurons and modulates the dopaminergic system. Eur J Neurosci 40:2479–2486. doi:10.1111/ejn.12600
Cramm M, Schmitz M, Karch A et al (2014) Characteristic CSF prion seeding efficiency in humans with prion diseases. Mol Neurobiol. doi:10.1007/s12035-014-8709-6
Koenig KA, Lowe MJ, Harrington DL et al (2014) Functional connectivity of primary motor cortex is dependent on genetic burden in prodromal Huntington disease. Brain Connect 4:535–546. doi:10.1089/brain.2014.0271
Szabadi E (2013) Functional neuroanatomy of the central noradrenergic system. J Psychopharmacol 27:659–693. doi:10.1177/0269881113490326
Elstner M, Morris CM, Heim K et al (2011) Expression analysis of dopaminergic neurons in Parkinson’s disease and aging links transcriptional dysregulation of energy metabolism to cell death. Acta Neuropathol 122:75–86. doi:10.1007/s00401-011-0828-9
Bae E-J, Yang N-Y, Song M et al (2014) Glucocerebrosidase depletion enhances cell-to-cell transmission of alpha-synuclein. Nat Commun 5:4755. doi:10.1038/ncomms5755
Ubeda-Banon I, Saiz-Sanchez D, de la Rosa-Prieto C, Martinez-Marcos A (2014) alpha-Synuclein in the olfactory system in Parkinson’s disease: role of neural connections on spreading pathology. Brain Struct Funct 219:1513–1526. doi:10.1007/s00429-013-0651-2
Riley BE, Gardai SJ, Emig-Agius D et al (2014) Systems-based analyses of brain regions functionally impacted in Parkinson’s disease reveals underlying causal mechanisms. PLoS One 9:e102909. doi:10.1371/journal.pone.0102909
Thaler A, Mirelman A, Helmich RC et al (2013) Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers. Cortex 49:2501–2511. doi:10.1016/j.cortex.2012.12.017
Yan J, Du L, Kim S et al (2014) Transcriptome-guided amyloid imaging genetic analysis via a novel structured sparse learning algorithm. Bioinformatics 30:i564–i571. doi:10.1093/bioinformatics/btu465
Campbell IM, Rao M, Arredondo SD et al (2013) Fusion of large-scale genomic knowledge and frequency data computationally prioritizes variants in epilepsy. PLoS Genet 9:e1003797. doi:10.1371/journal.pgen.1003797
Cherniak C (1990) The bounded brain: toward quantitative neuroanatomy. J Cogn Neurosci 2:58–68. doi:10.1162/jocn.1990.2.1.58
Azevedo FAC, Carvalho LRB, Grinberg LT et al (2009) Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol 513:532–541. doi:10.1002/cne.21974
Swanson LW (2000) What is the brain? Trends Neurosci 23:519–527
Swanson LW (2011) Brain architecture: understanding the basic plan, 2nd edn. Oxford University Press, New York
Stanton PK, Sejnowski TJ (1989) Associative long-term depression in the hippocampus induced by hebbian covariance. Nature 339:215–218. doi:10.1038/339215a0
Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31–39. doi:10.1038/361031a0
Allen NJ, Barres BA (2009) Neuroscience: Glia - more than just brain glue. Nature 457:675–677. doi:10.1038/457675a
Takano T, Tian G-F, Peng W et al (2006) Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 9:260–267. doi:10.1038/nn1623
Attwell D, Buchan AM, Charpak S et al (2010) Glial and neuronal control of brain blood flow. Nature 468:232–243. doi:10.1038/nature09613
Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871–927
Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312–318
Boyden ES, Zhang F, Bamberg E et al (2005) Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 8:1263–1268. doi:10.1038/nn1525
Sporns O, Tononi G, Edelman GM (2000) Connectivity and complexity: the relationship between neuroanatomy and brain dynamics. Neural Netw 13:909–922
Allen NJ (2014) Synaptic plasticity: astrocytes wrap it up. Curr Biol 24:R697–R699. doi:10.1016/j.cub.2014.06.030
Zhang J, Wang H, Ye C et al (2003) ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 40:971–982
Halassa MM, Fellin T, Haydon PG (2007) The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med 13:54–63. doi:10.1016/j.molmed.2006.12.005
Höfer T, Venance L, Giaume C (2002) Control and plasticity of intercellular calcium waves in astrocytes: a modeling approach. J Neurosci 22:4850–4859
Barker AJ, Ullian EM (2010) Astrocytes and synaptic plasticity. Neuroscientist 16:40–50. doi:10.1177/1073858409339215
Morrison BM, Lee Y, Rothstein JD (2013) Oligodendroglia: metabolic supporters of axons. Trends Cell Biol 23:644–651. doi:10.1016/j.tcb.2013.07.007
Fünfschilling U, Supplie LM, Mahad D et al (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485:517–521. doi:10.1038/nature11007
Paolicelli RC, Bolasco G, Pagani F et al (2011) Synaptic pruning by microglia is necessary for normal brain development. Science 333:1456–1458. doi:10.1126/science.1202529
Chung W-S, Clarke LE, Wang GX et al (2013) Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504:394–400. doi:10.1038/nature12776
Kreiter AK, Singer W (1996) Stimulus-dependent synchronization of neuronal responses in the visual cortex of the awake macaque monkey. J Neurosci 16:2381–2396
Cassidy M, Mazzone P, Oliviero A et al (2002) Movement-related changes in synchronization in the human basal ganglia. Brain 125:1235–1246
Lerche H, Shah M, Beck H et al (2013) Ion channels in genetic and acquired forms of epilepsy. J Physiol 591:753–764. doi:10.1113/jphysiol.2012.240606
Ragsdale DS (2008) How do mutant Nav1.1 sodium channels cause epilepsy? Brain Res Rev 58:149–159. doi:10.1016/j.brainresrev.2008.01.003
Lopes da Silva FH, Blanes W, Kalitzin SN et al (2003) Dynamical diseases of brain systems: different routes to epileptic seizures. IEEE Trans Biomed Eng 50:540–548. doi:10.1109/TBME.2003.810703
Jeha LE, Najm I, Bingaman W et al (2007) Surgical outcome and prognostic factors of frontal lobe epilepsy surgery. Brain 130:574–584. doi:10.1093/brain/awl364
Hong SL, Cossyleon D, Hussain WA et al (2012) Dysfunctional behavioral modulation of corticostriatal communication in the R6/2 mouse model of Huntington’s disease. PLoS One 7:e47026. doi:10.1371/journal.pone.0047026
Wellstead P, Cloutier M (2011) An energy systems approach to Parkinson’s disease. Wiley Interdiscip Rev Syst Biol Med 3:1–6. doi:10.1002/wsbm.107
Pissadaki EK, Bolam JP (2013) The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson’s disease. Front Comput Neurosci 7:13. doi:10.3389/fncom.2013.00013
Uhl GR (1998) Hypothesis: the role of dopaminergic transporters in selective vulnerability of cells in Parkinson’s disease. Ann Neurol 43:555–560. doi:10.1002/ana.410430503
Chauhan NB, Siegel GJ, Lee JM (2001) Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson’s disease brain. J Chem Neuroanat 21:277–288
Goedert M (2001) Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci 2:492–501. doi:10.1038/35081564
Goedert M, Spillantini MG, Del Tredici K, Braak H (2013) 100 years of Lewy pathology. Nat Rev Neurol 9:13–24. doi:10.1038/nrneurol.2012.242
Brown P (2003) Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson’s disease. Mov Disord 18:357–363. doi:10.1002/mds.10358
Benazzouz A, Hallett M (2000) Mechanism of action of deep brain stimulation. Neurology 55:S13–S16
Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10(Suppl):S10–S17. doi:10.1038/nm1066
Raj A, Kuceyeski A, Weiner M (2012) A network diffusion model of disease progression in dementia. Neuron 73:1204–1215. doi:10.1016/j.neuron.2011.12.040
Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357–366. doi:10.1002/ana.410380304
Van Praag H, Fleshner M, Schwartz MW, Mattson MP (2014) Exercise, energy intake, glucose homeostasis, and the brain. J Neurosci 34:15139–15149. doi:10.1523/JNEUROSCI.2814-14.2014
Somogyi P, Hodgson AJ, Smith AD (1979) An approach to tracing neuron networks in the cerebral cortex and basal ganglia. Combination of Golgi staining, retrograde transport of horseradish peroxidase and anterograde degeneration of synaptic boutons in the same material. Neuroscience 4:1805–1852
Gray EG (1959) Axo-somatic and axo-dendritic synapses of the cerebral cortex: an electron microscope study. J Anat 93:420–433
Colonnier M (1968) Synaptic patterns on different cell types in the different laminae of the cat visual cortex. An electron microscope study. Brain Res 9:268–287
Dhawale A, Bhalla US (2008) The network and the synapse: 100 years after Cajal. HFSP J 2:12–16. doi:10.2976/1.2835214
Roberts RC, Gaither LA, Peretti FJ et al (1996) Synaptic organization of the human striatum: a postmortem ultrastructural study. J Comp Neurol 374:523–534. doi:10.1002/(SICI)1096-9861(19961028)374:4<523::AID-CNE4>3.0.CO;2-3
Biederer T, Sara Y, Mozhayeva M et al (2002) SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science 297:1525–1531. doi:10.1126/science.1072356
Livet J, Weissman TA, Kang H et al (2007) Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 450:56–62. doi:10.1038/nature06293
Lichtman JW, Livet J, Sanes JR (2008) A technicolour approach to the connectome. Nat Rev Neurosci 9:417–422. doi:10.1038/nrn2391
Gomes FC, Spohr TC, Martinez R, Moura Neto V (2001) Cross-talk between neurons and glia: highlights on soluble factors. Braz J Med Biol Res 34:611–620
Piet R, Vargová L, Syková E et al (2004) Physiological contribution of the astrocytic environment of neurons to intersynaptic crosstalk. Proc Natl Acad Sci U S A 101:2151–2155. doi:10.1073/pnas.0308408100
Soriano J, Rodríguez Martínez M, Tlusty T, Moses E (2008) Development of input connections in neural cultures. Proc Natl Acad Sci U S A 105:13758–13763. doi:10.1073/pnas.0707492105
Van Bussel F, Kriener B, Timme M (2011) Inferring synaptic connectivity from spatio-temporal spike patterns. Front Comput Neurosci 5:3. doi:10.3389/fncom.2011.00003
Napoli A, Xie J, Obeid I (2014) Understanding the temporal evolution of neuronal connectivity in cultured networks using statistical analysis. BMC Neurosci 15:17. doi:10.1186/1471-2202-15-17
Tye KM, Deisseroth K (2012) Optogenetic investigation of neural circuits underlying brain disease in animal models. Nat Rev Neurosci 13:251–266. doi:10.1038/nrn3171
Zhang F, Gradinaru V, Adamantidis AR et al (2010) Optogenetic interrogation of neural circuits: technology for probing mammalian brain structures. Nat Protoc 5:439–456. doi:10.1038/nprot.2009.226
Fenno LE, Mattis J, Ramakrishnan C et al (2014) Targeting cells with single vectors using multiple-feature Boolean logic. Nat Methods 11:763–772. doi:10.1038/nmeth.2996
Deisseroth K, Feng G, Majewska AK et al (2006) Next-generation optical technologies for illuminating genetically targeted brain circuits. J Neurosci 26:10380–10386. doi:10.1523/JNEUROSCI.3863-06.2006
Papa M, De Luca C, Petta F et al (2014) Astrocyte-neuron interplay in maladaptive plasticity. Neurosci Biobehav Rev 42:35–54. doi:10.1016/j.neubiorev.2014.01.010
López-Hidalgo M, Schummers J (2014) Cortical maps: a role for astrocytes? Curr Opin Neurobiol 24:176–189. doi:10.1016/j.conb.2013.11.001
Gullo F, Maffezzoli A, Dossi E et al (2012) Classifying heterogeneity of spontaneous up-states: a method for revealing variations in firing probability, engaged neurons and Fano factor. J Neurosci Methods 203:407–417. doi:10.1016/j.jneumeth.2011.10.014
Chung K, Wallace J, Kim S-Y et al (2013) Structural and molecular interrogation of intact biological systems. Nature 497:332–337. doi:10.1038/nature12107
Ke M-T, Fujimoto S, Imai T (2013) SeeDB: a simple and morphology-preserving optical clearing agent for neuronal circuit reconstruction. Nat Neurosci 16:1154–1161. doi:10.1038/nn.3447
Ahrens MB, Li JM, Orger MB et al (2012) Brain-wide neuronal dynamics during motor adaptation in zebrafish. Nature 485:471–477. doi:10.1038/nature11057
Freeman J, Vladimirov N, Kawashima T et al (2014) Mapping brain activity at scale with cluster computing. Nat Methods 11:941–950. doi:10.1038/nmeth.3041
Calimera A, Macii E, Poncino M (2013) The Human Brain Project and neuromorphic computing. Funct Neurol 28:191–196
Tønnesen J, Sørensen AT, Deisseroth K et al (2009) Optogenetic control of epileptiform activity. Proc Natl Acad Sci U S A 106:12162–12167. doi:10.1073/pnas.0901915106
Heinrichs-Graham E, Wilson TW, Santamaria PM et al (2014) Neuromagnetic evidence of abnormal movement-related beta desynchronization in Parkinson’s disease. Cereb Cortex 24:2669–2678. doi:10.1093/cercor/bht121
Bullmore E, Sporns O (2012) The economy of brain network organization. Nat Rev Neurosci 13:336–349. doi:10.1038/nrn3214
Appel-Cresswell S, de la Fuente-Fernandez R, Galley S, McKeown MJ (2010) Imaging of compensatory mechanisms in Parkinson’s disease. Curr Opin Neurol 23:407–412. doi:10.1097/WCO.0b013e32833b6019
De Reus MA, van den Heuvel MP (2013) The parcellation-based connectome: limitations and extensions. Neuroimage 80:397–404. doi:10.1016/j.neuroimage.2013.03.053
Wen W, He Y, Sachdev P (2011) Structural brain networks and neuropsychiatric disorders. Curr Opin Psychiatry 24:219–225. doi:10.1097/YCO.0b013e32834591f8
Rombouts SARB, Damoiseaux JS, Goekoop R et al (2009) Model-free group analysis shows altered BOLD FMRI networks in dementia. Hum Brain Mapp 30:256–266. doi:10.1002/hbm.20505
Onias H, Viol A, Palhano-Fontes F et al (2013) Brain complex network analysis by means of resting state fMRI and graph analysis: will it be helpful in clinical epilepsy? Epilepsy Behav. doi:10.1016/j.yebeh.2013.11.019
Huang S, Li J, Ye J et al (2013) A sparse structure learning algorithm for Gaussian Bayesian Network identification from high-dimensional data. IEEE Trans Pattern Anal Mach Intell 35:1328–1342. doi:10.1109/TPAMI.2012.129
Baggio H-C, Sala-Llonch R, Segura B et al (2014) Functional brain networks and cognitive deficits in Parkinson’s disease. Hum Brain Mapp 35:4620–4634. doi:10.1002/hbm.22499
Toussaint P-J, Maiz S, Coynel D et al (2014) Characteristics of the default mode functional connectivity in normal ageing and Alzheimer’s disease using resting state fMRI with a combined approach of entropy-based and graph theoretical measurements. Neuroimage 101:778–786. doi:10.1016/j.neuroimage.2014.08.003
Abela E, Rummel C, Hauf M et al (2014) Neuroimaging of epilepsy: lesions, networks, oscillations. Clin Neuroradiol 24:5–15. doi:10.1007/s00062-014-0284-8
Tang CC, Eidelberg D (2010) Abnormal metabolic brain networks in Parkinson’s disease from blackboard to bedside. Prog Brain Res 184:161–176. doi:10.1016/S0079-6123(10)84008-7
Niethammer M, Tang CC, Ma Y et al (2013) Parkinson’s disease cognitive network correlates with caudate dopamine. Neuroimage 78:204–209. doi:10.1016/j.neuroimage.2013.03.070
Teune LK, Strijkert F, Renken RJ et al (2014) The Alzheimer’s disease-related glucose metabolic brain pattern. Curr Alzheimer Res 11:725–732
Crossley NA, Mechelli A, Scott J et al (2014) The hubs of the human connectome are generally implicated in the anatomy of brain disorders. Brain 137:2382–2395. doi:10.1093/brain/awu132
Coenen VA, Allert N, Paus S et al (2014) Modulation of the cerebello-thalamo-cortical network in thalamic deep brain stimulation for tremor: a diffusion tensor imaging study. Neurosurgery. doi:10.1227/NEU.0000000000000540
Park KM, Shin KJ, Ha SY et al (2014) Response to antiepileptic drugs in partial epilepsy with structural lesions on MRI. Clin Neurol Neurosurg 123:64–68. doi:10.1016/j.clineuro.2014.04.029
Liu Y, Yu C, Zhang X et al (2014) Impaired long distance functional connectivity and weighted network architecture in Alzheimer’s disease. Cereb Cortex 24:1422–1435. doi:10.1093/cercor/bhs410
Zhong Y, Huang L, Cai S et al (2014) Altered effective connectivity patterns of the default mode network in Alzheimer’s disease: an fMRI study. Neurosci Lett 578:171–175. doi:10.1016/j.neulet.2014.06.043
Schiff SJ (2010) Towards model-based control of Parkinson’s disease. Philos Trans A Math Phys Eng Sci 368:2269–2308. doi:10.1098/rsta.2010.0050
Stocco A, Lebiere C, Anderson JR (2010) Conditional routing of information to the cortex: a model of the basal ganglia’s role in cognitive coordination. Psychol Rev 117:541–574. doi:10.1037/a0019077
Redgrave P, Rodriguez M, Smith Y et al (2010) Goal-directed and habitual control in the basal ganglia: implications for Parkinson’s disease. Nat Rev Neurosci 11:760–772. doi:10.1038/nrn2915
Thibeault CM, Srinivasa N (2013) Using a hybrid neuron in physiologically inspired models of the basal ganglia. Front Comput Neurosci 7:88. doi:10.3389/fncom.2013.00088
Rummel C, Goodfellow M, Gast H et al (2013) A systems-level approach to human epileptic seizures. Neuroinformatics 11:159–173. doi:10.1007/s12021-012-9161-2
Olde Dubbelink KTE, Hillebrand A, Stoffers D et al (2014) Disrupted brain network topology in Parkinson’s disease: a longitudinal magnetoencephalography study. Brain 137:197–207. doi:10.1093/brain/awt316
Morales DA, Vives-Gilabert Y, Gomez-Anson B et al (2013) Predicting dementia development in Parkinson’s disease using Bayesian network classifiers. Psychiatry Res 213:92–98. doi:10.1016/j.pscychresns.2012.06.001
Cole DM, Oei NYL, Soeter RP et al (2013) Dopamine-dependent architecture of cortico-subcortical network connectivity. Cereb Cortex 23:1509–1516. doi:10.1093/cercor/bhs136
Seibyl J, Russell D, Jennings D, Marek K (2012) Neuroimaging over the course of Parkinson’s disease: from early detection of the at-risk patient to improving pharmacotherapy of later-stage disease. Semin Nucl Med 42:406–414. doi:10.1053/j.semnuclmed.2012.06.003
Rao JA, Harrington DL, Durgerian S et al (2014) Disruption of response inhibition circuits in prodromal Huntington disease. Cortex 58:72–85. doi:10.1016/j.cortex.2014.04.018
Nombela C, Rowe JB, Winder-Rhodes SE et al (2014) Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study. Brain 137:2743–2758. doi:10.1093/brain/awu201
Van Diessen E, Diederen SJH, Braun KPJ et al (2013) Functional and structural brain networks in epilepsy: what have we learned? Epilepsia 54:1855–1865. doi:10.1111/epi.12350
Stam CJ, Tewarie P, Van Dellen E et al (2014) The trees and the forest: characterization of complex brain networks with minimum spanning trees. Int J Psychophysiol 92:129–138. doi:10.1016/j.ijpsycho.2014.04.001
Otte WM, Dijkhuizen RM, van Meer MPA et al (2012) Characterization of functional and structural integrity in experimental focal epilepsy: reduced network efficiency coincides with white matter changes. PLoS One 7:e39078. doi:10.1371/journal.pone.0039078
Kalitzin S, Koppert M, Petkov G, da Silva FL (2014) Multiple oscillatory states in models of collective neuronal dynamics. Int J Neural Syst 24:1450020. doi:10.1142/S0129065714500208
Holt AB, Netoff TI (2014) Origins and suppression of oscillations in a computational model of Parkinson’s disease. J Comput Neurosci 37:505–521. doi:10.1007/s10827-014-0523-7
Thiele I, Swainston N, Fleming RMT et al (2013) A community-driven global reconstruction of human metabolism. Nat Biotechnol. doi:10.1038/nbt.2488
Jain S, van Kesteren RE, Heutink P (2012) High content screening in neurodegenerative diseases. J Vis Exp:e3452. doi: 10.3791/3452
Herrera F, Goncalves S, Outeiro TF (2012) Imaging protein oligomerization in neurodegeneration using bimolecular fluorescence complementation. Methods Enzymol 506:157–174. doi:10.1016/B978-0-12-391856-7.00033-0
Boassa D, Berlanga ML, Yang MA et al (2013) Mapping the subcellular distribution of alpha-synuclein in neurons using genetically encoded probes for correlated light and electron microscopy: implications for Parkinson’s disease pathogenesis. J Neurosci 33:2605–2615. doi:10.1523/JNEUROSCI.2898-12.2013
Meisel C, Kuehn C (2012) Scaling effects and spatio-temporal multilevel dynamics in epileptic seizures. PLoS One 7:e30371. doi:10.1371/journal.pone.0030371
Abuhassan K, Coyle D, Maguire LP (2012) Investigating the neural correlates of pathological cortical networks in Alzheimer’s disease using heterogeneous neuronal models. IEEE Trans Biomed Eng 59:890–896. doi:10.1109/TBME.2011.2181843
Piray P, Keramati MM, Dezfouli A et al (2010) Individual differences in nucleus accumbens dopamine receptors predict development of addiction-like behavior: a computational approach. Neural Comput 22:2334–2368. doi:10.1162/NECO_a_00009
Garcia-Reitboeck P, Anichtchik O, Dalley JW et al (2013) Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra. Exp Neurol 248:541–545. doi:10.1016/j.expneurol.2013.07.015
McKinstry SU, Karadeniz YB, Worthington AK et al (2014) Huntingtin is required for normal excitatory synapse development in cortical and striatal circuits. J Neurosci 34:9455–9472. doi:10.1523/JNEUROSCI.4699-13.2014
Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL et al (2012) An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489:391–399. doi:10.1038/nature11405
Lew MF (2011) The evidence for disease modification in Parkinson’s disease. Int J Neurosci 121(Suppl):18–26. doi:10.3109/00207454.2011.620194
Bartus RT, Weinberg MS, Samulski RJ (2014) Parkinson’s disease gene therapy: success by design meets failure by efficacy. Mol Ther 22:487–497. doi:10.1038/mt.2013.281
Lorenzi M, Beltramello A, Mercuri NB et al (2011) Effect of memantine on resting state default mode network activity in Alzheimer’s disease. Drugs Aging 28:205–217. doi:10.2165/11586440-000000000-00000
Fraschini M, Demuru M, Puligheddu M et al (2014) The re-organization of functional brain networks in pharmaco-resistant epileptic patients who respond to VNS. Neurosci Lett 580:153–157. doi:10.1016/j.neulet.2014.08.010
Ojemann GA, Ojemann J, Ramsey NF (2013) Relation between functional magnetic resonance imaging (fMRI) and single neuron, local field potential (LFP) and electrocorticography (ECoG) activity in human cortex. Front Hum Neurosci 7:34. doi:10.3389/fnhum.2013.00034
Hill NJ, Gupta D, Brunner P et al (2012) Recording human electrocorticographic (ECoG) signals for neuroscientific research and real-time functional cortical mapping. J Vis Exp. doi:10.3791/3993
Kemmotsu N, Kucukboyaci NE, Leyden KM et al (2014) Frontolimbic brain networks predict depressive symptoms in temporal lobe epilepsy. Epilepsy Res 108:1554–1563. doi:10.1016/j.eplepsyres.2014.08.018
Kahan J, Urner M, Moran R et al (2014) Resting state functional MRI in Parkinson’s disease: the impact of deep brain stimulation on “effective” connectivity. Brain 137:1130–1144. doi:10.1093/brain/awu027
Stypulkowski PH, Stanslaski SR, Jensen RM et al (2014) Brain stimulation for epilepsy--local and remote modulation of network excitability. Brain Stimul 7:350–358. doi:10.1016/j.brs.2014.02.002
Guo Y, Rubin JE (2011) Multi-site stimulation of subthalamic nucleus diminishes thalamocortical relay errors in a biophysical network model. Neural Netw 24:602–616. doi:10.1016/j.neunet.2011.03.010
De Munter JPJM, Melamed E, Wolters EC (2014) Stem cell grafting in parkinsonism--why, how and when. Parkinsonism Relat Disord 20(Suppl 1):S150–S153. doi:10.1016/S1353-8020(13)70036-1
Ben-Yehudah A, Easley CA 4th, Hermann BP et al (2010) Systems biology discoveries using non-human primate pluripotent stem and germ cells: novel gene and genomic imprinting interactions as well as unique expression patterns. Stem Cell Res Ther 1:24. doi:10.1186/scrt24
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Ostaszewski, M., Skupin, A., Balling, R. (2016). Neurological Diseases from a Systems Medicine Point of View. In: Schmitz, U., Wolkenhauer, O. (eds) Systems Medicine. Methods in Molecular Biology, vol 1386. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3283-2_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3283-2_11
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3282-5
Online ISBN: 978-1-4939-3283-2
eBook Packages: Springer Protocols